share_log

T2 Biosystems | SC 13G: Statement of acquisition of beneficial ownership by individuals-JACOB SAFIER(5.7%),JSAF HOLDINGS, LLC(5.7%)

T2 Biosystems | SC 13G: Statement of acquisition of beneficial ownership by individuals-JACOB SAFIER(5.7%),JSAF HOLDINGS, LLC(5.7%)

T2 Biosystems | SC 13G:超过5%持股股东披露文件-JACOB SAFIER(5.7%),JSAF HOLDINGS, LLC(5.7%)
美股SEC公告 ·  2024/11/07 10:07

Moomoo AI 已提取核心信息

On October 30, 2024, a significant filing was made with the United States Securities and Exchange Commission by JSAF Holdings, LLC and Jacob Safier, indicating a substantial investment in T2 Biosystems, Inc. The Schedule 13G filing, dated November 6, 2024, reveals that JSAF Holdings and Jacob Safier, as the portfolio manager, collectively own 1,000,000 shares of T2 Biosystems' common stock, which represents 5.7% of the company based on the number of shares reported as outstanding in T2 Biosystems' latest quarterly report. The filing specifies that this ownership stake is not intended for the purpose of changing or influencing the control of T2 Biosystems, nor is it connected with any transaction with such purpose or effect. The address for both JSAF Holdings and Jacob Safier is listed as The Wolfson Group, One State Street Plaza, New York, NY. The filing emphasizes that the information provided is accurate to the best of the signatories' knowledge after reasonable inquiry.
On October 30, 2024, a significant filing was made with the United States Securities and Exchange Commission by JSAF Holdings, LLC and Jacob Safier, indicating a substantial investment in T2 Biosystems, Inc. The Schedule 13G filing, dated November 6, 2024, reveals that JSAF Holdings and Jacob Safier, as the portfolio manager, collectively own 1,000,000 shares of T2 Biosystems' common stock, which represents 5.7% of the company based on the number of shares reported as outstanding in T2 Biosystems' latest quarterly report. The filing specifies that this ownership stake is not intended for the purpose of changing or influencing the control of T2 Biosystems, nor is it connected with any transaction with such purpose or effect. The address for both JSAF Holdings and Jacob Safier is listed as The Wolfson Group, One State Street Plaza, New York, NY. The filing emphasizes that the information provided is accurate to the best of the signatories' knowledge after reasonable inquiry.
2024年10月30日,JSAF Holdings, LLC和Jacob Safier向美国证券交易委员会提交了一份重要的申报,显示在t2 biosystems有着重大投资。截至2024年11月6日的13G表格显示,JSAF Holdings和作为投资组合经理的Jacob Safier共同拥有t2 biosystems普通股100万股,占公司已报告的在外流通股份的5.7%。申报特别指出,此持股不打算改变或影响对t2 biosystems的控制,也与任何具有此目的或效果的交易无关。JSAF Holdings和Jacob Safier的地址均列在道富银行,纽约州纽约市One State Street Plaza。申报强调,提供的信息经过合理调查,据签署人的知识准确无误。
2024年10月30日,JSAF Holdings, LLC和Jacob Safier向美国证券交易委员会提交了一份重要的申报,显示在t2 biosystems有着重大投资。截至2024年11月6日的13G表格显示,JSAF Holdings和作为投资组合经理的Jacob Safier共同拥有t2 biosystems普通股100万股,占公司已报告的在外流通股份的5.7%。申报特别指出,此持股不打算改变或影响对t2 biosystems的控制,也与任何具有此目的或效果的交易无关。JSAF Holdings和Jacob Safier的地址均列在道富银行,纽约州纽约市One State Street Plaza。申报强调,提供的信息经过合理调查,据签署人的知识准确无误。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息